|
|
|
Insider
Information: |
Mitchell Dean J |
Relationship: |
Director |
City: |
Plainsboro |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
727,061 |
|
Indirect Shares
|
750 |
|
|
Direct
Value |
$4,115,477 |
|
|
Indirect Value
|
$28,418 |
|
|
Total
Shares |
727,811 |
|
|
Total
Value |
$4,143,895 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
Percentage
Gain/Loss : |
43.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
President, U.S. Primar... |
2003-09-10 |
60,000 |
2003-09-10 |
567 |
Premium* |
|
MGI Pharma Inc |
MOGN |
President, MGI, GP, In... |
2005-10-05 |
3,391 |
2005-10-05 |
183 |
Premium* |
|
ISTA Pharmaceuticals Inc |
ISTA |
Director |
2008-12-10 |
4,932 |
2007-10-11 |
0 |
Premium* |
|
Talecris Biotherapeutics Holding... |
TLCR |
Director |
2011-06-01 |
0 |
2010-04-01 |
0 |
Premium* |
|
Precigen Inc |
PGEN |
Director |
2024-03-14 |
503,183 |
|
0 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-05-08 |
80,555 |
2015-04-22 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2015-11-17 |
0 |
Premium* |
|
Praxis Precision Medicines, Inc. |
PRAX |
Director |
2023-03-24 |
75,000 |
2023-03-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
officerTitle |
|
2003-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
60,000 |
|
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
Director |
|
2007-10-11 |
4 |
A |
$0.00 |
$2 |
D/D |
2,466 |
2,466 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
Director |
|
2008-12-10 |
4 |
A |
$0.00 |
$2 |
D/D |
2,466 |
4,932 |
0 |
- |
|
TLCR |
Talecris Biotherapeutics ... |
Director |
|
2010-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,019 |
3,019 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2013-09-10 |
4 |
A |
$26.76 |
$1,499 |
D/D |
56 |
3,903 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2013-10-31 |
4 |
A |
$21.20 |
$742 |
D/D |
35 |
3,938 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2013-12-17 |
4 |
A |
$19.83 |
$2,221 |
D/D |
112 |
4,050 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2014-02-18 |
4 |
A |
$27.68 |
$747 |
D/D |
27 |
4,077 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2014-03-20 |
4 |
A |
$30.72 |
$69,980 |
D/D |
2,278 |
6,355 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2015-03-12 |
4 |
A |
$47.48 |
$69,986 |
D/D |
1,474 |
7,829 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Director |
|
2015-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2016-03-10 |
4 |
A |
$34.99 |
$69,980 |
D/D |
2,000 |
9,829 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Director |
|
2016-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
12,000 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,274 |
13,103 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Director |
|
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
18,000 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2018-03-23 |
4 |
A |
$15.80 |
$56,485 |
D/D |
3,575 |
21,678 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Director |
|
2018-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,186 |
26,186 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2019-03-08 |
4 |
A |
$5.06 |
$56,500 |
D/D |
11,166 |
32,844 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Director |
|
2019-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,385 |
34,571 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2020-03-13 |
4 |
A |
$2.01 |
$56,499 |
D/D |
28,109 |
102,473 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Director |
|
2020-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,635 |
41,206 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2021-03-25 |
4 |
A |
$7.71 |
$56,499 |
D/D |
7,328 |
177,926 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Director |
|
2021-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
9,828 |
51,034 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2022-02-22 |
4 |
A |
$2.03 |
$56,499 |
D/D |
27,832 |
205,758 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
|
|
2022-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
9,852 |
60,886 |
0 |
- |
|
57 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|